Preemptive/preventive health, pandemic preparedness, life science innovation and competitiveness, biomanufacturing, AI policy and regulation, rare disease policy and regulation, platform technology policy and regulation, broad based investment in US biotech
2026 · 3rd Quarter (July 1 - Sep 30)
FLAGSHIP PIONEERING
Filed by TARPLIN, DOWNS & YOUNG, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2026
- Income
- $80,000.00
- Expenses
- Not reported
- Registrant
- TARPLIN, DOWNS & YOUNG, LLC
- Client
- FLAGSHIP PIONEERING
- Filing UUID
- 44e2a992-d798-4472-8082-9dc79a27e45b
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
federal budget issues
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.